Tenet Healthcare Corporation
$ 232.26
2.61%
12 Feb - close price
- Market Cap 20,520,403,000 USD
- Current Price $ 232.26
- High / Low $ 235.77 / 223.80
- Stock P/E 15.38
- Book Value 48.35
- EPS 15.10
- Next Earning Report 2026-05-05
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.07 %
- ROE 0.27 %
- 52 Week High 235.77
- 52 Week Low 109.82
About
Tenet Healthcare Corporation is a diversified health services company. The company is headquartered in Dallas, Texas.
Analyst Target Price
$249.62
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-11 | 2025-10-28 | 2025-07-22 | 2025-04-28 | 2025-02-06 | 2024-10-29 | 2024-07-24 | 2024-04-30 | 2024-02-08 | 2023-10-30 | 2023-07-31 | 2023-04-25 |
| Reported EPS | 4.7 | 3.7 | 4.02 | 4.36 | 3.44 | 2.93 | 2.31 | 3.22 | 2.68 | 1.44 | 1.44 | 1.42 |
| Estimated EPS | 4.02 | 3.34 | 2.66 | 3.17 | 2.8324 | 2.37 | 1.9 | 1.43 | 1.6 | 1.2 | 1.25 | 1.16 |
| Surprise | 0.68 | 0.36 | 1.36 | 1.19 | 0.6076 | 0.56 | 0.41 | 1.79 | 1.08 | 0.24 | 0.19 | 0.26 |
| Surprise Percentage | 16.9154% | 10.7784% | 51.1278% | 37.5394% | 21.4518% | 23.6287% | 21.5789% | 125.1748% | 67.5% | 20% | 15.2% | 22.4138% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-05 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 4.42 |
| Currency | USD |
Previous Dividend Records
| Jan 1970 | |
|---|---|
| Payment Date | None |
| Amount | $0.01 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: THC
2026-02-12 20:36:38
UBS has re-affirmed its "Buy" rating for Tenet Healthcare (THC) and increased its price target to $288, up from $260, indicating strong confidence in the stock's future. This adjustment aligns with a generally positive sentiment from several analysts who have recently raised their price targets for the Dallas-based healthcare services organization. Despite the positive analyst outlook, GuruFocus's GF Value estimates a potential downside for THC, suggesting a divergence in valuation perspectives.
2026-02-12 13:57:38
Tenet Healthcare Corporation (NYSE:THC) reported strong Q4 and full-year 2025 earnings, exceeding expectations with $21.3 billion in net operating revenues and $4.57 billion in consolidated adjusted EBITDA for the full year. The company's USPI segment continued robust growth, and the Hospital segment also showed significant improvement. For 2026, Tenet projects adjusted EBITDA between $4.485 billion and $4.785 billion, anticipating continued demand and strategic investments, despite headwinds from expiring enhanced premium tax credits.
2026-02-12 12:57:38
KeyBanc has increased its price target for Tenet Healthcare (NYSE:THC) to $250 from $225, reiterating an Overweight rating. This decision follows Tenet's strong fourth-quarter results and optimistic 2026 guidance, which led to a 17% surge in the company's shares. KeyBanc highlighted the company's potential for significant efficiency gains and elevated healthcare services utilization as key drivers for long-term value.
2026-02-12 09:57:38
Tenet Healthcare (THC) reported strong Q4 CY2025 results, beating revenue and adjusted EPS expectations, driven by growth in its ambulatory surgical center business, disciplined expense management, and a favorable payer mix. Despite projected headwinds from the phase-out of enhanced premium tax credits, the company plans to offset these impacts through continued technology investments, ambulatory expansion, and structural cost initiatives. Management is focused on operational efficiencies, strategic M&A, and leveraging its Conifer unit to support future growth and navigate a challenging reimbursement environment.
2026-02-11 20:57:40
Tenet Healthcare has successfully revitalized its operations since late 2017 by divesting underperforming assets, improving governance, and enhancing efficiency. The company is strategically focused on expanding its high-margin ambulatory surgery business, which offers better growth prospects than its acute hospital operations. These efforts have led to consistent returns on invested capital that exceed the weighted average cost of capital, positioning Tenet to address future challenges effectively.
2026-02-11 18:27:33
Tenet Healthcare reported a strong Q4 2025 with net operating revenues reaching $5.527 billion and adjusted diluted EPS rising 36.6% to $4.70. The company also provided an upbeat 2026 outlook, projecting net operating revenues between $21.5 billion and $22.3 billion. Despite remaining below its 52-week high, Tenet's shares have shown resilience and a positive longer-term trend.
